Expression of LacdiNAc Groups on N-Glycans among Human Tumors Is Complex

Aberrant glycosylation of proteins and lipids is one of the characteristic features of malignantly transformed cells. The GalNAcβ1 → 4GlcNAc (LacdiNAc or LDN) group at the nonreducing termini of both N- and O-glycans is not generally found in mammalian cells. We previously showed that the expression...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BioMed research international 2014, Vol.2014 (2014), p.1-7
Hauptverfasser: Hirano, Kiyoko, Matsuda, Akio, Shirai, Takashi, Furukawa, Kiyoshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7
container_issue 2014
container_start_page 1
container_title BioMed research international
container_volume 2014
creator Hirano, Kiyoko
Matsuda, Akio
Shirai, Takashi
Furukawa, Kiyoshi
description Aberrant glycosylation of proteins and lipids is one of the characteristic features of malignantly transformed cells. The GalNAcβ1 → 4GlcNAc (LacdiNAc or LDN) group at the nonreducing termini of both N- and O-glycans is not generally found in mammalian cells. We previously showed that the expression level of the LacdiNAc group in N-glycans decreases dramatically during the progression of human breast cancer. In contrast, the enhanced expression of the LacdiNAc group has been shown to be associated with the progression of human prostate, ovarian, and pancreatic cancers. Therefore, the expression of the disaccharide group appears to be dependent on types of tumors. The mechanism of formation of the LacdiNAc group in human tumors and cancer cells has been studied, and two β4-N-acetylgalacto-saminyltransferases (β4GalNAcTs), β4GalNAcT3 and β4GalNAcT4, have been shown to be involved in the biosynthesis of this disaccharide group in a tissue-dependent manner. Transfection of the β4GalNAcT3 gene brought about significant changes in the malignant phenotypes of human neuroblastoma, indicating that this disaccharide group is important for suppressing the tumor growth.
doi_str_mv 10.1155/2014/981627
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4066867</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A427025250</galeid><sourcerecordid>A427025250</sourcerecordid><originalsourceid>FETCH-LOGICAL-c558t-348d9288b0f975679cd1131ccd80d1fb88b6d7fdef0899e63430c752df7e6db93</originalsourceid><addsrcrecordid>eNpdkctr3DAQxkVpaUKSU84thl4KxYlGL1uXwrKku4ElvSRnodVj62BLrrQuyX9fLZuaNLqMmPnxzeND6BLwFQDn1wQDu5YtCNK8Q6eEAqsFMHg__yk9QRc5P-LyCoal-IhOCMeYAuWnaH3zNCaXcxdDFX210cZ2dwtTrVKcxlyV7F296p-NDrnSQwy7aj0NOlT30xBTrm5ztYzD2Lunc_TB6z67i5d4hh5-3Nwv1_Xm5-p2udjUhvN2X1PWWknadou9bLhopLEAFIyxLbbgt6UibOOt87iV0gnKKDYNJ9Y3TtitpGfo-1F3nLaDs8aFfdK9GlM36PSsou7U_5XQ_VK7-EcxLEQrmiLw9UUgxd-Ty3s1dNm4vtfBxSkrEAClLUhe0C9v0Mc4pVDWU-X2hAnJynwztdO9U13wsfQ1B1G1YKTBhJdzF-rbkTIp5pycn0cGrA5WqoOV6mhloT-_3nJm_xlXgE9HwJW883omeHGcAP0LB5yfoQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1552469434</pqid></control><display><type>article</type><title>Expression of LacdiNAc Groups on N-Glycans among Human Tumors Is Complex</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>Wiley-Blackwell Open Access Titles</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Hirano, Kiyoko ; Matsuda, Akio ; Shirai, Takashi ; Furukawa, Kiyoshi</creator><creatorcontrib>Hirano, Kiyoko ; Matsuda, Akio ; Shirai, Takashi ; Furukawa, Kiyoshi</creatorcontrib><description>Aberrant glycosylation of proteins and lipids is one of the characteristic features of malignantly transformed cells. The GalNAcβ1 → 4GlcNAc (LacdiNAc or LDN) group at the nonreducing termini of both N- and O-glycans is not generally found in mammalian cells. We previously showed that the expression level of the LacdiNAc group in N-glycans decreases dramatically during the progression of human breast cancer. In contrast, the enhanced expression of the LacdiNAc group has been shown to be associated with the progression of human prostate, ovarian, and pancreatic cancers. Therefore, the expression of the disaccharide group appears to be dependent on types of tumors. The mechanism of formation of the LacdiNAc group in human tumors and cancer cells has been studied, and two β4-N-acetylgalacto-saminyltransferases (β4GalNAcTs), β4GalNAcT3 and β4GalNAcT4, have been shown to be involved in the biosynthesis of this disaccharide group in a tissue-dependent manner. Transfection of the β4GalNAcT3 gene brought about significant changes in the malignant phenotypes of human neuroblastoma, indicating that this disaccharide group is important for suppressing the tumor growth.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2014/981627</identifier><identifier>PMID: 25003135</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Puplishing Corporation</publisher><subject>Analysis ; Bioengineering ; Biosynthesis ; Breast cancer ; Care and treatment ; Cell adhesion &amp; migration ; Cell Transformation, Neoplastic - metabolism ; Cell Transformation, Neoplastic - pathology ; Colleges &amp; universities ; Complications and side effects ; Development and progression ; Gene expression ; Glycoproteins ; Humans ; Influence ; Lactose - analogs &amp; derivatives ; Lactose - metabolism ; Neoplasms - metabolism ; Neoplasms - pathology ; Pancreatic cancer ; Polysaccharides - metabolism ; Prostate cancer ; Review ; Rodents ; Tumors</subject><ispartof>BioMed research international, 2014, Vol.2014 (2014), p.1-7</ispartof><rights>COPYRIGHT 2014 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2014 Kiyoko Hirano et al. Kiyoko Hirano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2014 Kiyoko Hirano et al. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c558t-348d9288b0f975679cd1131ccd80d1fb88b6d7fdef0899e63430c752df7e6db93</citedby><cites>FETCH-LOGICAL-c558t-348d9288b0f975679cd1131ccd80d1fb88b6d7fdef0899e63430c752df7e6db93</cites><orcidid>0000-0001-5505-1030 ; 0000-0002-7408-9306</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066867/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066867/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,4025,27928,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25003135$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hirano, Kiyoko</creatorcontrib><creatorcontrib>Matsuda, Akio</creatorcontrib><creatorcontrib>Shirai, Takashi</creatorcontrib><creatorcontrib>Furukawa, Kiyoshi</creatorcontrib><title>Expression of LacdiNAc Groups on N-Glycans among Human Tumors Is Complex</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Aberrant glycosylation of proteins and lipids is one of the characteristic features of malignantly transformed cells. The GalNAcβ1 → 4GlcNAc (LacdiNAc or LDN) group at the nonreducing termini of both N- and O-glycans is not generally found in mammalian cells. We previously showed that the expression level of the LacdiNAc group in N-glycans decreases dramatically during the progression of human breast cancer. In contrast, the enhanced expression of the LacdiNAc group has been shown to be associated with the progression of human prostate, ovarian, and pancreatic cancers. Therefore, the expression of the disaccharide group appears to be dependent on types of tumors. The mechanism of formation of the LacdiNAc group in human tumors and cancer cells has been studied, and two β4-N-acetylgalacto-saminyltransferases (β4GalNAcTs), β4GalNAcT3 and β4GalNAcT4, have been shown to be involved in the biosynthesis of this disaccharide group in a tissue-dependent manner. Transfection of the β4GalNAcT3 gene brought about significant changes in the malignant phenotypes of human neuroblastoma, indicating that this disaccharide group is important for suppressing the tumor growth.</description><subject>Analysis</subject><subject>Bioengineering</subject><subject>Biosynthesis</subject><subject>Breast cancer</subject><subject>Care and treatment</subject><subject>Cell adhesion &amp; migration</subject><subject>Cell Transformation, Neoplastic - metabolism</subject><subject>Cell Transformation, Neoplastic - pathology</subject><subject>Colleges &amp; universities</subject><subject>Complications and side effects</subject><subject>Development and progression</subject><subject>Gene expression</subject><subject>Glycoproteins</subject><subject>Humans</subject><subject>Influence</subject><subject>Lactose - analogs &amp; derivatives</subject><subject>Lactose - metabolism</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>Pancreatic cancer</subject><subject>Polysaccharides - metabolism</subject><subject>Prostate cancer</subject><subject>Review</subject><subject>Rodents</subject><subject>Tumors</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkctr3DAQxkVpaUKSU84thl4KxYlGL1uXwrKku4ElvSRnodVj62BLrrQuyX9fLZuaNLqMmPnxzeND6BLwFQDn1wQDu5YtCNK8Q6eEAqsFMHg__yk9QRc5P-LyCoal-IhOCMeYAuWnaH3zNCaXcxdDFX210cZ2dwtTrVKcxlyV7F296p-NDrnSQwy7aj0NOlT30xBTrm5ztYzD2Lunc_TB6z67i5d4hh5-3Nwv1_Xm5-p2udjUhvN2X1PWWknadou9bLhopLEAFIyxLbbgt6UibOOt87iV0gnKKDYNJ9Y3TtitpGfo-1F3nLaDs8aFfdK9GlM36PSsou7U_5XQ_VK7-EcxLEQrmiLw9UUgxd-Ty3s1dNm4vtfBxSkrEAClLUhe0C9v0Mc4pVDWU-X2hAnJynwztdO9U13wsfQ1B1G1YKTBhJdzF-rbkTIp5pycn0cGrA5WqoOV6mhloT-_3nJm_xlXgE9HwJW883omeHGcAP0LB5yfoQ</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Hirano, Kiyoko</creator><creator>Matsuda, Akio</creator><creator>Shirai, Takashi</creator><creator>Furukawa, Kiyoshi</creator><general>Hindawi Puplishing Corporation</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><general>Hindawi Publishing Corporation</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5505-1030</orcidid><orcidid>https://orcid.org/0000-0002-7408-9306</orcidid></search><sort><creationdate>2014</creationdate><title>Expression of LacdiNAc Groups on N-Glycans among Human Tumors Is Complex</title><author>Hirano, Kiyoko ; Matsuda, Akio ; Shirai, Takashi ; Furukawa, Kiyoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c558t-348d9288b0f975679cd1131ccd80d1fb88b6d7fdef0899e63430c752df7e6db93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Analysis</topic><topic>Bioengineering</topic><topic>Biosynthesis</topic><topic>Breast cancer</topic><topic>Care and treatment</topic><topic>Cell adhesion &amp; migration</topic><topic>Cell Transformation, Neoplastic - metabolism</topic><topic>Cell Transformation, Neoplastic - pathology</topic><topic>Colleges &amp; universities</topic><topic>Complications and side effects</topic><topic>Development and progression</topic><topic>Gene expression</topic><topic>Glycoproteins</topic><topic>Humans</topic><topic>Influence</topic><topic>Lactose - analogs &amp; derivatives</topic><topic>Lactose - metabolism</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>Pancreatic cancer</topic><topic>Polysaccharides - metabolism</topic><topic>Prostate cancer</topic><topic>Review</topic><topic>Rodents</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hirano, Kiyoko</creatorcontrib><creatorcontrib>Matsuda, Akio</creatorcontrib><creatorcontrib>Shirai, Takashi</creatorcontrib><creatorcontrib>Furukawa, Kiyoshi</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hirano, Kiyoko</au><au>Matsuda, Akio</au><au>Shirai, Takashi</au><au>Furukawa, Kiyoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of LacdiNAc Groups on N-Glycans among Human Tumors Is Complex</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2014</date><risdate>2014</risdate><volume>2014</volume><issue>2014</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Aberrant glycosylation of proteins and lipids is one of the characteristic features of malignantly transformed cells. The GalNAcβ1 → 4GlcNAc (LacdiNAc or LDN) group at the nonreducing termini of both N- and O-glycans is not generally found in mammalian cells. We previously showed that the expression level of the LacdiNAc group in N-glycans decreases dramatically during the progression of human breast cancer. In contrast, the enhanced expression of the LacdiNAc group has been shown to be associated with the progression of human prostate, ovarian, and pancreatic cancers. Therefore, the expression of the disaccharide group appears to be dependent on types of tumors. The mechanism of formation of the LacdiNAc group in human tumors and cancer cells has been studied, and two β4-N-acetylgalacto-saminyltransferases (β4GalNAcTs), β4GalNAcT3 and β4GalNAcT4, have been shown to be involved in the biosynthesis of this disaccharide group in a tissue-dependent manner. Transfection of the β4GalNAcT3 gene brought about significant changes in the malignant phenotypes of human neuroblastoma, indicating that this disaccharide group is important for suppressing the tumor growth.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Puplishing Corporation</pub><pmid>25003135</pmid><doi>10.1155/2014/981627</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-5505-1030</orcidid><orcidid>https://orcid.org/0000-0002-7408-9306</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2314-6133
ispartof BioMed research international, 2014, Vol.2014 (2014), p.1-7
issn 2314-6133
2314-6141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4066867
source MEDLINE; PubMed Central Open Access; Wiley-Blackwell Open Access Titles; PubMed Central; Alma/SFX Local Collection
subjects Analysis
Bioengineering
Biosynthesis
Breast cancer
Care and treatment
Cell adhesion & migration
Cell Transformation, Neoplastic - metabolism
Cell Transformation, Neoplastic - pathology
Colleges & universities
Complications and side effects
Development and progression
Gene expression
Glycoproteins
Humans
Influence
Lactose - analogs & derivatives
Lactose - metabolism
Neoplasms - metabolism
Neoplasms - pathology
Pancreatic cancer
Polysaccharides - metabolism
Prostate cancer
Review
Rodents
Tumors
title Expression of LacdiNAc Groups on N-Glycans among Human Tumors Is Complex
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T12%3A30%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20LacdiNAc%20Groups%20on%20N-Glycans%20among%20Human%20Tumors%20Is%20Complex&rft.jtitle=BioMed%20research%20international&rft.au=Hirano,%20Kiyoko&rft.date=2014&rft.volume=2014&rft.issue=2014&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2014/981627&rft_dat=%3Cgale_pubme%3EA427025250%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1552469434&rft_id=info:pmid/25003135&rft_galeid=A427025250&rfr_iscdi=true